DOV PHARMACEUTICAL INC Insider Trading Transactions
Get free email notifications about insider trading for DOV PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOV PHARMACEUTICAL INC. DOV PHARMACEUTICAL INC is CEO and President in Euthymics Bioscience Inc ($DOVP) and Chief Financial Officer in Euthymics Bioscience Inc ($DOVP) and Director in Euthymics Bioscience Inc ($DOVP) and S.V.P. & CSO in Euthymics Bioscience Inc ($DOVP) and Sr. V.P. & C.S.O. in Euthymics Bioscience Inc ($DOVP) and Sr. V.P. & CSO in Euthymics Bioscience Inc ($DOVP) and Sr. V.P. Drug Development in Euthymics Bioscience Inc ($DOVP) and Sr. V.P. Research Chief Scienc in Euthymics Bioscience Inc ($DOVP) and Sr. V.P. Research Chief Scient in Euthymics Bioscience Inc ($DOVP) and Sr. V.P. Research, CSO in Euthymics Bioscience Inc ($DOVP) and SVP & CFO in Euthymics Bioscience Inc ($DOVP) and SVP & CSO in Euthymics Bioscience Inc ($DOVP) and SVP and CFO in Euthymics Bioscience Inc ($DOVP) and V.P. & General Counsel in Euthymics Bioscience Inc ($DOVP).
Latest Insider Trading Transactions of DOV PHARMACEUTICAL INC
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.53 | 5,000 | 77,650 | 1,459,800 | 1.5 M to 1.5 M (-0.34 %) |
Aug 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.42 | 30,000 | 462,600 | 1,193,730 | 1.2 M to 1.2 M (-2.45 %) |
Jul 09 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Grant | A | 13.55 | 15,000 | 203,250 | 203,200 | 188.2 K to 203.2 K (+7.97 %) |
Jul 09 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Grant | A | 13.55 | 15,000 | 203,250 | 69,300 | 54.3 K to 69.3 K (+27.62 %) |
Jul 09 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Grant | A | 13.55 | 15,000 | 203,250 | 121,200 | 106.2 K to 121.2 K (+14.12 %) |
Jun 07 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.00 | 100,000 | 1,500,000 | 1,223,730 | 1.3 M to 1.2 M (-7.55 %) |
May 19 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.11 | 20,000 | 302,200 | 61,000 | 81 K to 61 K (-24.69 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.50 | 10,000 | 155,000 | 1,323,730 | 1.3 M to 1.3 M (-0.75 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.51 | 5,000 | 77,550 | 1,333,730 | 1.3 M to 1.3 M (-0.37 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.56 | 2,500 | 38,900 | 1,338,730 | 1.3 M to 1.3 M (-0.19 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.59 | 2,500 | 38,975 | 1,341,230 | 1.3 M to 1.3 M (-0.19 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.50 | 20,000 | 310,000 | 1,343,730 | 1.4 M to 1.3 M (-1.47 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.40 | 15,000 | 231,000 | 1,363,730 | 1.4 M to 1.4 M (-1.09 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.24 | 2,500 | 38,100 | 1,378,730 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.10 | 2,500 | 37,750 | 1,381,230 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.08 | 2,500 | 37,700 | 1,383,730 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.05 | 2,500 | 37,625 | 1,386,230 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.00 | 7,500 | 112,500 | 1,388,730 | 1.4 M to 1.4 M (-0.54 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.00 | 5,000 | 75,000 | 1,396,230 | 1.4 M to 1.4 M (-0.36 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.07 | 2,500 | 37,675 | 1,401,230 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.23 | 5,000 | 76,150 | 1,403,730 | 1.4 M to 1.4 M (-0.35 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.22 | 5,000 | 76,100 | 1,408,730 | 1.4 M to 1.4 M (-0.35 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.21 | 2,000 | 30,420 | 1,413,730 | 1.4 M to 1.4 M (-0.14 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.25 | 3,000 | 45,750 | 1,415,730 | 1.4 M to 1.4 M (-0.21 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.45 | 1,000 | 15,450 | 1,418,730 | 1.4 M to 1.4 M (-0.07 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.40 | 4,000 | 61,600 | 1,419,730 | 1.4 M to 1.4 M (-0.28 %) |
Apr 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 17.70 | 300 | 5,310 | 19,500 | 19.8 K to 19.5 K (-1.52 %) |
Apr 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 17.69 | 1,110 | 19,636 | 19,800 | 20.9 K to 19.8 K (-5.31 %) |
Apr 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 17.67 | 1,000 | 17,670 | 20,910 | 21.9 K to 20.9 K (-4.56 %) |
Apr 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 17.63 | 700 | 12,341 | 21,910 | 22.6 K to 21.9 K (-3.10 %) |
Apr 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 17.60 | 1,890 | 33,264 | 22,610 | 24.5 K to 22.6 K (-7.71 %) |
Apr 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 17.55 | 1,000 | 17,550 | 24,500 | 25.5 K to 24.5 K (-3.92 %) |
Apr 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Sell | S | 17.00 | 18,400 | 312,800 | 125,000 | 143.4 K to 125 K (-12.83 %) |
Apr 08 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research C ... | Sell | S | 17.15 | 8,000 | 137,200 | 325,000 | 333 K to 325 K (-2.40 %) |
Mar 25 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research C ... | Sell | S | 16.34 | 12,000 | 196,080 | 333,000 | 345 K to 333 K (-3.48 %) |
Mar 22 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research C ... | Sell | S | 16.30 | 20,000 | 326,000 | 365,000 | 385 K to 365 K (-5.19 %) |
Mar 11 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | J | 0.00 | 41,535 | 0 | 120,465 | 162 K to 120.5 K (-25.64 %) |
Mar 02 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 13.08 | 54,500 | 712,860 | 50,800 | 105.3 K to 50.8 K (-51.76 %) |
Feb 17 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Option Exercise | A | 13.28 | 25,000 | 332,000 | 233,371 | |
Feb 17 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Option Exercise | A | 13.28 | 25,000 | 332,000 | 275,000 | |
Feb 17 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research C ... | Option Exercise | A | 100,000.00 | 100,000 | 10,000,000,000 | 465,000 | |
Feb 17 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 13.28 | 25,000 | 332,000 | 235,600 | |
Feb 17 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 13.28 | 25,000 | 332,000 | 235,600 | |
Jan 28 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Option Exercise | S | 2.78 | 2,500 | 6,950 | 18,400 | |
Jan 28 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Sell | S | 13.70 | 2,500 | 34,250 | 18,400 | 20.9 K to 18.4 K (-11.96 %) |
Jan 28 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Buy | M | 2.78 | 20,900 | 58,102 | 20,900 | 0 to 20.9 K |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | C | 2.73 | 162,000 | 442,260 | 0 | |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | C | 2.47 | 48,600 | 120,042 | 0 | |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | C | 2.73 | 162,000 | 442,260 | 162,000 | |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | C | 2.47 | 48,600 | 120,042 | 48,600 | |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Option Exercise | M | 4.40 | 250,000 | 1,100,000 | 250,000 | |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Option Exercise | S | 2.78 | 19,600 | 54,488 | 20,900 | |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Buy | M | 2.78 | 20,900 | 58,102 | 20,900 | 0 to 20.9 K |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Sell | S | 13.71 | 6,000 | 82,260 | 20,900 | 26.9 K to 20.9 K (-22.30 %) |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Sell | S | 13.84 | 1,600 | 22,144 | 26,900 | 28.5 K to 26.9 K (-5.61 %) |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Sell | S | 13.73 | 12,000 | 164,760 | 40,500 | 52.5 K to 40.5 K (-22.86 %) |
Jan 15 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Buy | M | 2.78 | 40,500 | 112,590 | 40,500 | 0 to 40.5 K |
Dec 30 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Option Exercise | M | 4.01 | 324,500 | 1,301,245 | 324,500 | |
Dec 30 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Option Exercise | S | 4.01 | 25,000 | 100,250 | 349,500 | |
Dec 30 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Option Exercise | S | 4.01 | 15,000 | 60,150 | 364,500 | |
Dec 30 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Option Exercise | M | 4.01 | 364,500 | 1,461,645 | 364,500 | |
Dec 30 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Sell | S | 13.39 | 25,000 | 334,750 | 0 | 25 K to 0 (-100.00 %) |
Dec 30 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Buy | M | 4.01 | 25,000 | 100,250 | 25,000 | 0 to 25 K |
Dec 30 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Sell | S | 13.42 | 15,000 | 201,300 | 0 | 15 K to 0 (-100.00 %) |
Dec 30 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Buy | M | 4.01 | 15,000 | 60,150 | 15,000 | 0 to 15 K |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.43 | 100 | 1,443 | 56,097 | 56.2 K to 56.1 K (-0.18 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.36 | 291 | 4,179 | 56,388 | 56.7 K to 56.4 K (-0.51 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.39 | 400 | 5,756 | 56,788 | 57.2 K to 56.8 K (-0.70 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.45 | 9 | 130 | 56,797 | 56.8 K to 56.8 K (-0.02 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.51 | 300 | 4,353 | 57,097 | 57.4 K to 57.1 K (-0.52 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.52 | 1,000 | 14,520 | 58,097 | 59.1 K to 58.1 K (-1.69 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.53 | 868 | 12,612 | 58,965 | 59.8 K to 59 K (-1.45 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.83 | 10 | 148 | 58,975 | 59 K to 59 K (-0.02 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.96 | 1,267 | 18,954 | 60,242 | 61.5 K to 60.2 K (-2.06 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.95 | 8,233 | 123,083 | 68,475 | 76.7 K to 68.5 K (-10.73 %) |
Sep 19 2003 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.92 | 3,725 | 55,577 | 72,200 | 75.9 K to 72.2 K (-4.91 %) |